Results 51 to 60 of about 69,625 (317)
Acute Medicine & Surgery, 2022 Background Although pump‐controlled retrograde trial off (PCRTO) is a practical method for weaning from venoarterial extracorporeal membrane oxygenation (VA‐ECMO), its advantages and safety for patients with pulmonary embolism are not yet reported.
Kazuki Matsumura +4 more
doaj +1 more source
Conversion from Venovenous to Venoarterial Extracorporeal Membrane Oxygenation in Adults
Membranes, 2021 No major study has been performed on the conversion from venovenous (VV) to venoarterial (VA) extracorporeal membrane oxygenation (ECMO) in adults. This single-center retrospective cohort study aimed to investigate the incidence, indication, and outcome ...
Lars Falk +3 more
doaj +1 more source
Critical Care, 2020 The World Health Organization (WHO) has characterized the disease, coronavirus disease 2019 (COVID-19), as a pandemic on March 11, 2020 (www.who.int). As of March 11, the WHO had recorded a total of 118,326 confirmed COVID-19 cases, with 4292 death cases
Yingchun Zeng +5 more
semanticscholar +1 more source
Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients
Physiological Reports, 2021 Current knowledge on the use of extracorporeal membrane oxygenation (ECMO) in COVID‐19 remains limited to small series and registry data. In the present retrospective monocentric study, we report on our experience, our basic principles, and our results ...
R. Giraud +8 more
semanticscholar +1 more source
Predictors of intracranial hemorrhage in neonatal patients on extracorporeal membrane oxygenation
Scientific Reports, 2023 Extracorporeal membrane oxygenation (ECMO) is a life-supportive treatment in neonatal patients with refractory lung and/or heart failure. Intracranial hemorrhage (ICH) is a severe complication and reliable predictors are warranted. The aims of this study
Sara Wood +6 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 Background: Mortality of patients suffering from critical illness has been dramatically improved with advanced technological development of extracorporeal membrane oxygenation (ECMO) therapy.
Yu Zheng +19 more
doaj +1 more source
What Should We Learn From Early Hemodialysis Allocation About How We Should Be Using ECMO? [PDF]
, 2019 Early hemodialysis allocation deliberations should inform our current considerations of what constitutes reasonable uses of extracorporeal membrane oxygenation.
bosslet, Gabriel T., Gutteridge, Daniel
core +1 more source
Critical Care, 2016 Extracorporeal membrane oxygenation (ECMO) is a technology capable of providing short-term mechanical support to the heart, lungs or both. Over the last decade, the number of centres offering ECMO has grown rapidly.
J. Millar +4 more
semanticscholar +1 more source
Surgical treatment of the left ventricular assist device drive line infection with abscess formation [PDF]
Scripta Medica, 2018 Specific left ventricular assist device infections are the leading cause of morbidity and second most common cause of death in patients who survive the first six months after implanting device, and also they are the most common cause of readmissions to ...
Terzic Duško +6 more
doaj
The ECMO specialist’s role in troubleshooting ECMO emergencies
The Egyptian Journal of Critical Care Medicine, 2018 Whether a patient still has native lung function or not, respiratory extracorporeal membrane oxygenation (ECMO) complications need an immediate response from the ECMO team assigned to the patient. Methodological troubleshooting can be a key aspect to responding to an ECMO emergency if the cause of the issue is not clearly identifiable.
Guillaume Alinier +4 more
openaire +4 more sources